Even today, with a multitude of tests and technologies, the exact cause of infectious diseases can go undiagnosed. Understanding bacteria, viruses, fungi and parasites depends on comprehensive genomic information, which is why we believe metagenomic Next-Generation Sequencing (mNGS) is the key to discovering how microorganisms influence our health and ensure sustainability.
With mNGS, accurate diagnosis can be made, plus rare, novel or unexpected pathogens can be identified. Yet, mNGS is not yet widely used in research or clinical settings for a number of technical and cost issues. At Micronbrane Medical, we take a systematic approach to removing any barriers to ubiquitous use of mNGS, from collection to action, to revolutionize the study, diagnosis, tracking and treatment of infectious diseases.
Products for all sample
types and any
application
Novel host depletion
and microbial
enrichment
mNGS-grade reagents
Genomic DNA assays
(not cell-free DNA)
Cost and resource efficient
Evaluation of a mNGS Assay with Novel Host Depletion Method for Pathogen Identification in Septic Patients
Study Identifies Key Contamination Sources in Metagenomic Sequencing:
Micronbrane Medical sets a new standard for mNGS-grade reagents to enhance the accuracy of pathogen identification.
Conquering the Contaminome: Realizing the Promise of Metagenomic Next-Generation Sequencing
Micronbrane Medical technologies enrich our understanding of microorganisms through innovative collection devices, novel host depletion, mNGS-grade reagents, advanced metagenomic sequencing assays, plus rapid bioinformatic software.
© 2024 Micronbrane Medical
